Cargando…

Prognostic factors at the time of diagnosis of metastatic breast cancer.

Detalles Bibliográficos
Autores principales:	Robertson, J. F., Blamey, R. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063169/ https://www.ncbi.nlm.nih.gov/pubmed/9823986

Ejemplares similares

Potential for cost economies in guiding therapy in patients with metastatic breast cancer.
por: Robertson, J. F., et al.
Publicado: (1995)

Early-onset breast cancer--histopathological and prognostic considerations.
por: Kollias, J., et al.
Publicado: (1997)

Season of initial detection in breast cancer.
por: Galea, M. H., et al.
Publicado: (1991)

Response in post-menopausal patients on ICI 118630.
por: Robertson, J. F., et al.
Publicado: (1987)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

E-cadherin as a prognostic indicator in primary breast cancer
por: Parker, C, et al.
Publicado: (2001)

A prognostic index in primary breast cancer.
por: Haybittle, J. L., et al.
Publicado: (1982)

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
por: Dixon, A. R., et al.
Publicado: (1993)

Detection of prognostic factors in metastatic breast cancer
por: Tazhibi, Mehdi, et al.
Publicado: (2013)

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.
por: Pinder, S. E., et al.
Publicado: (1995)

Frequency of screening for breast cancer
por: Blamey, R.W.
Publicado: (1989)

Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990)

Confirmation of a prognostic index in primary breast cancer.
por: Todd, J. H., et al.
Publicado: (1987)

An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
por: Williams, M. R., et al.
Publicado: (1990)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
por: Robertson, J. F., et al.
Publicado: (1992)

Objective measurement of therapeutic response in breast cancer using tumour markers.
por: Robertson, J. F., et al.
Publicado: (1991)

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
por: Dixon, A. R., et al.
Publicado: (1990)

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
por: Owainati, A. A., et al.
Publicado: (1987)

Prognostic factors of breast cancer liver metastasis surgery
por: Treska, Vladislav, et al.
Publicado: (2015)

Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
por: Stravodimou, Athina, et al.
Publicado: (2013)

Early but Quality Diagnosis: On Breast Cancer and Its Risk Factors [Letter]
por: Zehra, Syeda Sakina, et al.
Publicado: (2023)

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
por: Travis, A., et al.
Publicado: (1996)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
por: Parkes, Amanda, et al.
Publicado: (2018)

Prognostic factors for patients with metastatic breast cancer: a literature review
por: Hu, Mengyu, et al.
Publicado: (2021)

Metallothionein expression in human breast cancer.
por: Goulding, H., et al.
Publicado: (1995)

Prognostic value of the S-phase fraction of breast cancer.
por: Remvikos, Y.
Publicado: (1993)

Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients
por: Orlandini, L.F., et al.
Publicado: (2021)

Challenges in the diagnosis of breast cancer in the elderly
por: Belli, AK, et al.
Publicado: (2015)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Imaging diagnosis of metastatic breast cancer
por: Pesapane, Filippo, et al.
Publicado: (2020)

Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
por: Ho-Yen, C, et al.
Publicado: (2013)

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
por: Lovekin, C., et al.
Publicado: (1991)

Prognostic factors for patients with hepatic metastases from breast cancer
por: Wyld, L, et al.
Publicado: (2003)

Prognostic factors in breast cancer.
por: Miller, W. R.
Publicado: (1992)

Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research
por: Rea, D, et al.
Publicado: (2015)

Pulmonary artery pseudoaneurysm secondary to metastatic breast cancer
por: Shum, Pey Ling, et al.
Publicado: (2018)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.
por: Howell, A., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_lnegmdo5lobvpsf5pdmk88tari